Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial

BACKGROUND: Neoadjuvant chemotherapy with S-1 plus oxaliplatin (SOX regimen) has shown promising results in pathological response rate and survival rate in patients with locally advanced resectable gastric cancer (LAGC). We previously carried out the SPACE study to assess efficacy and safety of low-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Lanlan, Tian, Yitong, Wang, Kangxin, Tang, Jie, Liu, Jin, Zhang, Jiaguang, Wang, Min, Liu, Jie, Xu, Hao, Chen, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830353/
https://www.ncbi.nlm.nih.gov/pubmed/36636043
http://dx.doi.org/10.21037/jgo-22-1158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830353/
https://www.ncbi.nlm.nih.gov/pubmed/36636043
http://dx.doi.org/10.21037/jgo-22-1158

Ejemplares similares